Notice: This company has been marked as potentially delisted and may not be actively trading. Zealand Pharma A/S (ZEAL) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO saysOctober 12, 2024 | msn.comZealand Pharma targeting 'next generation' of obesity drugs, CEO saysOctober 12, 2024 | msn.comNovo and Eli contender Zealand Pharma heralds its obesity drug alternative: It's our 'crown jewel'October 11, 2024 | msn.comZealand Pharma seeks partner for its 'next generation' weight loss drugOctober 11, 2024 | msn.comZealand : Boehringer Gets FDA Breakthrough Therapy Designation For Survodutide In Non-Cirrhotic MASHOctober 9, 2024 | markets.businessinsider.comDenmark's Zealand provides US FDA update on drug for low blood sugar in infantsOctober 9, 2024 | msn.comFDA declines to approve Zealand Pharma’s hypoglycaemia therapy in infantsOctober 9, 2024 | finance.yahoo.comZealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinismOctober 8, 2024 | globenewswire.comZealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutideOctober 8, 2024 | globenewswire.comDeutsche initiates coverage on Zealand Pharma shares with Hold ratingOctober 4, 2024 | uk.investing.comHidden Gems in India's Stock Market for September 2024September 24, 2024 | uk.finance.yahoo.comDiscovering India's Hidden Stock Gems In September 2024September 24, 2024 | uk.finance.yahoo.comArrowhead Pharmaceuticals seeks approval for obesity treatment trial in New ZealandSeptember 24, 2024 | finance.yahoo.comDenmark stocks lower at close of trade; OMX Copenhagen 20 down 1.79%September 19, 2024 | msn.comMore Than $3 Billion At Stake: How Regulatory Red Tape Is Holding Back Australia's Cannabis LegalizationSeptember 17, 2024 | benzinga.comZealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18thSeptember 13, 2024 | globenewswire.comZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsSeptember 12, 2024 | globenewswire.comZealand Pharma Announces Positive Topline Data From Phase 1b Trial Of DapiglutideSeptember 9, 2024 | markets.businessinsider.comZealand to Broaden Trial of Weight-Loss Drug After Early SuccessSeptember 9, 2024 | msn.comZealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutideSeptember 9, 2024 | globenewswire.comTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsAugust 30, 2024 | globenewswire.comZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsAugust 22, 2024 | globenewswire.comThis Rising Biotech Is a Fantastic Weight-Loss Stock to Buy NowAugust 22, 2024 | msn.comZealand Pharma rebound after prior session lossesAugust 20, 2024 | investing.comEuropean markets slightly higher to start the new trading week; Zealand Pharma down 4.7%August 19, 2024 | msn.comMpox Gives Denmark Yet Another Way to Show Its Pharma DominanceAugust 16, 2024 | uk.news.yahoo.comZealand Pharma major shareholder announcement: Bank of America CorporationAugust 16, 2024 | globenewswire.comNew Zealand Charity Unknowingly Distributed Meth-Laced CandyAugust 15, 2024 | yahoo.comHow Roche passed on a potential $14bn-a-year weight-loss pillAugust 15, 2024 | ft.comEvaxion Biotech A/S (NASDAQ:EVAX) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.comZealand Pharma Announces Financial Results for the First Half of 2024August 15, 2024 | globenewswire.comDavid Seymour's ‘whole of society’ plan for tipping millions of dollars more in to Pharmac - and Big PharmaAugust 12, 2024 | msn.comZealand Pharma: A Bit FrothyJuly 30, 2024 | seekingalpha.comTwo Dozen Patients Are Worth Billions in Pharma’s Hot MarketJuly 24, 2024 | finance.yahoo.comTwo Dozen Patients Are Worth Billions in Pharma’s Hottest MarketJuly 23, 2024 | bloomberg.comInside the Western world's 'made in China' addictionJuly 21, 2024 | msn.comMissed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its PortfolioJuly 5, 2024 | fool.comZealand Pharma major shareholder announcement: Van Herk InvestmentsJune 28, 2024 | globenewswire.comZealand Pharma completes registration of capital increaseJune 28, 2024 | globenewswire.comZealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billionJune 25, 2024 | globenewswire.comZealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billionJune 25, 2024 | globenewswire.comZealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billionJune 25, 2024 | globenewswire.comZealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintideJune 20, 2024 | globenewswire.comZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsJune 13, 2024 | globenewswire.comZealand Pharma announces that Boehringer Ingelheim's survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosisJune 7, 2024 | globenewswire.comZealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASLJune 6, 2024 | globenewswire.comZealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASLJune 6, 2024 | globenewswire.comZealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines AgencyMay 31, 2024 | globenewswire.comZealand Pharma to participate in upcoming healthcare investor conferences in June 2024May 29, 2024 | globenewswire.comZealand Pharma major shareholder announcement: Polar CapitalMay 29, 2024 | globenewswire.com Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you! Click here to reserve your spot at the emergency crypto summit now. ZEAL Media Mentions By Week ZEAL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZEAL News Sentiment▼1.080.43▲Average Medical News Sentiment ZEAL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZEAL Articles This Week▼02▲ZEAL Articles Average Week Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTC Therapeutics News Today Edgewise Therapeutics News Today Xenon Pharmaceuticals News Today Zai Lab News Today MoonLake Immunotherapeutics News Today Rhythm Pharmaceuticals News Today Bausch Health Companies News Today MorphoSys News Today Protagonist Therapeutics News Today Janux Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZEAL) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zealand Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Zealand Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZEAL Stock Alerts